These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 979659)

  • 21. Failre of suppress plasma glucagon concentrations by orally administered glucose in diabetic patients after treatment.
    Seino Y; Ikeda M; Kurahachi H; Taminato T; Sakurai H; Goto Y; Inoue Y; Kadowaki S; Mori K; Imura H
    Diabetes; 1978 Dec; 27(12):1145-50. PubMed ID: 363490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The inhibitory effect of somatostatin on growth hormone, insulin and glucagon secretion in diabetes mellitus.
    Ward FR; Leblanc H; Yen SS
    J Clin Endocrinol Metab; 1975 Sep; 41(3):527-32. PubMed ID: 1159060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal alpha cell function in human diabetes: the response to oral protein.
    Raskin P; Aydin I; Yamamoto T; Unger RH
    Am J Med; 1978 Jun; 64(6):988-97. PubMed ID: 350047
    [No Abstract]   [Full Text] [Related]  

  • 24. Glucose counterregulation in patients after pancreatectomy. Comparison with other clinical forms of diabetes.
    Polonsky KS; Herold KC; Gilden JL; Bergenstal RM; Fang VS; Moossa AR; Jaspan JB
    Diabetes; 1984 Nov; 33(11):1112-9. PubMed ID: 6389228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormalities of endogenous glucagon and insulin in unstable diabetes.
    Reynolds C; Molnar GD; Horwitz DL; Rubenstein AH; Taylor WF; Jiang NS
    Diabetes; 1977 Jan; 26(1):36-45. PubMed ID: 830563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of glucose on the glucagon response to L-dopa in normal and diabetic subjects.
    Klimes I; Vigas M; Jurcovicová J; Repceková D; Kolesár P
    Diabetes; 1978 Apr; 27(4):396-9. PubMed ID: 640244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin and glucagon ratio in the patho-physiology of diabetic ketoacidosis and hyperosmolar hyperglycemic non-ketotic diabetes.
    Wahid M; Naveed AK; Hussain I
    J Coll Physicians Surg Pak; 2006 Jan; 16(1):11-4. PubMed ID: 16441980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A-Cell and gut glucagon in normal and depancreatized dogs. Inhibition by somatostatin and insulin.
    Matsuyama T; Wider MD; Tanaka R; Shima K; Tarui S; Nishikawa M; Foà PP
    Diabete Metab; 1979 Jun; 5(2):141-7. PubMed ID: 478084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes in the glucagon and growth hormone levels in the blood plasma of healthy persons and of patients with disordered glucose tolerance after insulin administration].
    Tikhonova NE; Alekseeva GG
    Probl Endokrinol (Mosk); 1986; 32(1):22-5. PubMed ID: 3513155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The role of gastrin in regulating insulin and glucagon secretion in patients with diabetes mellitus].
    Starosel'tseva LK; Kniazeva AP; Belovalova IM; Abduraimova GR
    Probl Endokrinol (Mosk); 1988; 34(4):20-5. PubMed ID: 3057484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cortisol, glucagon and growth hormone responses to oral glucose in non-insulin-dependent diabetes in the young.
    Jialal I; Joubert SM
    S Afr Med J; 1982 Oct; 62(16):549-52. PubMed ID: 6750813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucagon and diabetes.
    Pek S
    Clin Endocrinol Metab; 1977 Jul; 6(2):333-44. PubMed ID: 142590
    [No Abstract]   [Full Text] [Related]  

  • 33. Glucose counterregulation in diabetes secondary to chronic pancreatitis.
    Larsen S; Hilsted J; Philipsen EK; Tronier B; Christensen NJ; Damkjaer Nielsen M; Worning H
    Metabolism; 1990 Feb; 39(2):138-43. PubMed ID: 1967815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum pancreatic polypeptide and glucagon immunoreactivity in fasting healthy and diabetic children.
    Walczak M; Mrozikiewicz D; Dmochowski K; Rewers M; Cichy W
    Mater Med Pol; 1989; 21(1):38-42. PubMed ID: 2699344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible role of alpha-cell insulin resistance in exaggerated glucagon responses to arginine in type 2 diabetes.
    Tsuchiyama N; Takamura T; Ando H; Sakurai M; Shimizu A; Kato K; Kurita S; Kaneko S
    Diabetes Care; 2007 Oct; 30(10):2583-7. PubMed ID: 17644622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperglucagonemia in liver cirrhosis with portal-systemic venous anastomoses: responses of plasma glucagon and gastric inhibitory polypeptide to oral or intravenous glucose in cirrhotics with normal or elevated fasting plasma glucose levels.
    McDonald TJ; Dupre J; Caussignac Y; Radziuk J; Van Vliet S
    Metabolism; 1979 Apr; 28(4):300-7. PubMed ID: 449682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of exogenous hyperglucagonemia in insulin-treated diabetics.
    Raskin P; Unger RH
    Diabetes; 1977 Nov; 26(11):1034-9. PubMed ID: 410690
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of insulin on the exaggerated glucagon response to arginine stimulation in diabetes mellitus.
    Raskin P; Aydin I; Unger RH
    Diabetes; 1976 Mar; 25(3):227-9. PubMed ID: 1254112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma glucagon and alanine responses to acute insulin deficiency in man.
    Gerich JE; Tsalikian E; Lorenzi M; Karam JH; Bier DM
    J Clin Endocrinol Metab; 1975 Mar; 40(3):526-9. PubMed ID: 1117061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Twenty-four-hour somatostatin infusions in normals, juvenile diabetics, and maturity-onset diabetics.
    Christensen SE; Hansen AP; Orskov H; Lundbaek K
    Metabolism; 1978 Sep; 27(9 Suppl 1):1427-31. PubMed ID: 683011
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.